Mulvihill, Mark J.,Steinig, Arno G.,Crew, Andrew Philip,Jin, Meizhong,Kleinberg, Andrew,Li, An-Hu,Wang, Jing
申请号：
AU2011252784
公开号：
AU2011252784A1
申请日:
2011.05.16
申请国别(地区):
AU
年份:
2012
代理人:
摘要：
Compounds of Formula I, as shown below and defined herein: (I) pharmaceutically acceptable salts thereof, synthesis, intermediates, formulations, and methods of disease treatment therewith, including treatment of cancers, such as tumors driven at least in part by at least one of RON, MET or ALK. This Abstract is not limiting of the invention.
